Bayer says glyphosate settlement talks delayed by coronavirus-Handelsblatt
FRANKFURT (Reuters) – Talks between Bayer AG (BAYGn.DE) and plaintiff lawyers to settle claims that the German company’s glyphosate-based weedkillers cause cancer have been slowed by the coronavirus pandemic, Bayer’s Chief Executive told daily Handelsblatt.
“This is about currently not being able to meet in person for talks. All this of course slows down the negotiations,” CEO Werner Baumann told the newspaper in an interview published on Thursday.